RedHill Biopharma Ltd. (RDHL)

7.08
0.08 1.14
NASDAQ : Health Technology
Prev Close 7.00
Open 7.01
Day Low/High 6.93 / 7.17
52 Wk Low/High 4.30 / 11.25
Volume 70.00K
Avg Volume 81.10K
Exchange NASDAQ
Shares Outstanding 21.27M
Market Cap 145.74M
EPS -2.60
P/E Ratio 26.92
Div & Yield N.A. (N.A)

Latest News

Celgene Down After Pulling Plug on Crohn's Disease Drug Study -- Biotech Movers

Celgene Down After Pulling Plug on Crohn's Disease Drug Study -- Biotech Movers

The Summit, N.J.-based firm said Thursday that it was discontinuing the GED-0301 (mongersen) Phase 3 Revolve study in Crohn's disease and the extension trial.

TheStreet Quant Rating: D- (Sell)